Poly Medicure Ltd

Poly Medicure Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Poly Medicure Ltd

₹ 2,589 -0.72%
21 Nov - close price
polymedicure.com BSE: 531768 NSE: POLYMED
About

Poly Medicure Limited is an India-based manufacturer and exporter of medical devices. The Company exports plastic medical disposables/surgical devices.[1]

Key Points

Product Portfolio
It is a medical devices company with product portfolio comprises of more than 130 SKUs of medical devices in the product verticals of infusion therapy, oncology, anesthesia and respiratory care, urology, gastroenterology, blood management and blood collection, surgery and wound drainage, dialysis, central venous access catheters, veterinary medical devices, and others. [1]

Website BSE NSE
  • Market Cap ₹ 26,279 Cr.
  • Current Price ₹ 2,589
  • High / Low ₹ 3,358 / 1,361
  • Stock P/E 90.2
  • Book Value ₹ 254
  • Dividend Yield 0.12 %
  • ROCE 21.9 %
  • ROE 17.6 %
  • Face Value ₹ 5.00
Edit ratios

Pros

  • Company is almost debt free.
  • Company has delivered good profit growth of 29.2% CAGR over last 5 years

Cons

  • Stock is trading at 10.2 times its book value
  • Promoter holding has decreased over last quarter: -3.47%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Part of Nifty Smallcap 250 BSE Allcap Nifty 500 BSE SmallCap Nifty 500 Multicap 50:25:25

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
212 220 244 239 264 272 293 306 320 321 361 367 402
161 169 188 191 198 203 212 220 237 236 264 266 290
Operating Profit 50 51 57 48 66 68 82 85 83 84 97 101 113
OPM % 24% 23% 23% 20% 25% 25% 28% 28% 26% 26% 27% 28% 28%
12 7 9 5 9 14 9 13 13 17 16 17 27
Interest 0 -1 1 1 0 5 2 2 2 3 3 3 3
Depreciation 13 13 14 14 14 14 15 15 15 16 16 19 20
Profit before tax 50 46 51 38 61 64 73 81 78 82 94 96 117
Tax % 25% 25% 25% 24% 26% 26% 22% 25% 24% 25% 25% 25% 25%
37 34 38 29 45 48 57 61 59 61 71 72 87
EPS in Rs 3.89 3.57 4.01 3.00 4.71 4.96 5.99 6.31 6.17 6.41 7.35 7.53 8.61
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
252 312 373 393 439 507 586 646 746 879 1,068 1,306 1,452
199 238 288 307 345 386 452 483 536 665 801 954 1,056
Operating Profit 52 74 85 86 94 122 134 162 210 214 266 353 396
OPM % 21% 24% 23% 22% 21% 24% 23% 25% 28% 24% 25% 27% 27%
0 11 28 8 13 14 16 19 19 39 36 57 76
Interest 7 9 10 10 8 11 13 20 10 5 10 13 12
Depreciation 12 14 18 20 23 28 36 39 46 53 56 62 71
Profit before tax 34 62 84 65 76 96 100 122 173 195 237 335 389
Tax % 29% 31% 27% 27% 26% 27% 34% 24% 25% 25% 24% 25%
24 43 61 47 56 70 66 92 130 146 179 252 292
EPS in Rs 2.73 4.88 6.92 5.36 6.37 7.96 7.51 10.47 13.51 15.23 18.66 26.23 29.90
Dividend Payout % 9% 20% 18% 28% 39% 25% 27% 19% 19% 16% 16% 11%
Compounded Sales Growth
10 Years: 15%
5 Years: 17%
3 Years: 21%
TTM: 22%
Compounded Profit Growth
10 Years: 21%
5 Years: 29%
3 Years: 22%
TTM: 30%
Stock Price CAGR
10 Years: 27%
5 Years: 65%
3 Years: 41%
1 Year: 71%
Return on Equity
10 Years: 18%
5 Years: 17%
3 Years: 15%
Last Year: 18%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 11 22 22 22 44 44 44 44 48 48 48 48 51
Reserves 100 122 170 202 225 290 336 385 906 1,029 1,186 1,410 2,524
49 67 76 79 97 127 150 194 126 111 137 165 151
52 71 87 73 83 93 103 117 107 146 167 199 279
Total Liabilities 212 282 354 376 449 555 633 740 1,187 1,334 1,538 1,821 3,005
89 120 161 177 201 260 272 328 389 451 598 831 929
CWIP 8 20 10 14 20 18 19 25 21 43 78 71 62
Investments 7 6 6 6 6 18 42 58 385 384 181 221 1,143
108 137 178 180 222 258 300 330 392 456 681 699 871
Total Assets 212 282 354 376 449 555 633 740 1,187 1,334 1,538 1,821 3,005

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
38 65 63 62 55 76 113 127 116 126 197 256
-30 -58 -57 -30 -54 -87 -104 -106 -434 -89 -189 -237
-8 6 -9 -31 -1 14 -10 -22 319 -40 -8 -17
Net Cash Flow 0 13 -2 1 0 3 -1 -1 1 -2 -0 2

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 61 53 58 75 79 81 77 68 73 80 76 72
Inventory Days 144 140 146 105 193 207 138 241 202 210 222 194
Days Payable 100 102 103 77 136 130 93 144 104 109 95 89
Cash Conversion Cycle 105 91 101 103 136 157 123 165 171 181 203 177
Working Capital Days 55 31 42 64 82 93 80 70 104 113 108 98
ROCE % 27% 33% 30% 26% 25% 26% 23% 25% 21% 16% 19% 22%

Shareholding Pattern

Numbers in percentages

Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
44.76% 44.66% 53.34% 53.33% 53.33% 53.32% 53.32% 53.17% 53.17% 53.14% 66.02% 62.56%
14.13% 15.07% 15.59% 16.27% 16.33% 16.21% 15.61% 14.49% 14.10% 12.37% 9.91% 11.88%
2.99% 3.33% 3.25% 3.39% 3.38% 3.67% 4.25% 5.15% 5.46% 7.21% 9.34% 12.33%
38.11% 36.94% 27.82% 27.02% 26.97% 26.79% 26.82% 27.20% 27.28% 27.25% 14.72% 13.23%
No. of Shareholders 35,16633,83133,29634,23932,01535,39336,14134,64936,05336,71236,85238,352

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls